Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
2.160
0.00 (0.00%)
At close: Jul 16, 2026, 4:00 PM EDT
2.150
-0.010 (-0.46%)
Pre-market: Jul 17, 2026, 4:05 AM EDT
Seer, Inc. Market Cap
Seer, Inc. has a market cap or net worth of $118.76 million as of July 16, 2026. Its market cap has decreased by -3.90% in one year.
Market Cap
118.76M
Enterprise Value
-24.88M
1-Year Change
-3.90%
Ranking
Category
Stock Price
$2.16
ChartMarket Cap Chart
Since the IPO on December 4, 2020, Seer, Inc.'s market cap has decreased from $3.27B to $118.76M, a decrease of -96.37%. That is a compound annual growth rate of -44.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 118.76M | 15.37% |
| Dec 31, 2025 | 102.94M | -24.43% |
| Dec 31, 2024 | 136.21M | 10.01% |
| Dec 29, 2023 | 123.82M | -65.92% |
| Dec 30, 2022 | 363.32M | -74.19% |
| Dec 31, 2021 | 1.41B | -57.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| enGene Therapeutics | 128.62M |
| Cue Biopharma | 127.52M |
| Genelux | 127.45M |
| ProMIS Neurosciences | 124.56M |
| Spruce Biosciences | 123.85M |
| Anixa Biosciences | 122.48M |
| Fortress Biotech | 122.25M |
| Vivani Medical | 118.62M |